Last 12 months
Inside the activity.
1 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 1 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 19, 2026 Filed Sep 10, 2026 17:29 UTC |
Dash Barry HDirector
|
PurchaseCommon Stock | 30,000 | $0.29 | $8,610.00 |
DisclosureSEC source: 0001324222-26-000001 · primary_doc.xml · nonDerivative · entry 1 Dash Barry H · CIK 0001324222 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,265,555 Read SEC document |
| January 09, 2026 Filed Jan 13, 2026 21:35 UTC |
Plassche DouglasEVP Operations
|
Exercise / conversionStock Options (right to buy) · Derivative | 2,500,000 | $0.00 Strike: $0.03 | $0.00 |
DisclosureSEC source: 0001493152-26-002062 · ownership.xml · derivative · entry 2 Plassche Douglas · CIK 0001600946 · EVP Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,500,000 shares Expires 2033-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: All of the stock options were fully vested and exercisable as of the transaction date. Read SEC document |
| January 09, 2026 Filed Jan 13, 2026 21:35 UTC |
Plassche DouglasEVP Operations
|
Exercise / conversionStock Options (right to buy) | 2,500,000 | $0.03 | $75,000.00 |
DisclosureSEC source: 0001493152-26-002062 · ownership.xml · nonDerivative · entry 1 Plassche Douglas · CIK 0001600946 · EVP Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,000,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 02, 2025 Filed Oct 4, 2025 01:58 UTC |
Plassche DouglasEVP Operations
|
Salecommon stock | 800,000 | $0.62 | $499,200.00 |
DisclosureSEC source: 0001493152-25-016979 · ownership.xml · nonDerivative · entry 1 Plassche Douglas · CIK 0001600946 · EVP Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,500,000 Read SEC document |
| August 25, 2025 Filed Aug 26, 2025 21:17 UTC |
ELITE PHARMACEUTICALS INC /NV/EVP Operations
|
Exercise / conversionStock Options (right to buy) · Derivative | 2,500,000 | $0.00 Strike: $0.03 | $0.00 |
DisclosureSEC source: 0001493152-25-012347 · ownership.xml · derivative · entry 3 ELITE PHARMACEUTICALS INC /NV/ · CIK 0001053369 · EVP Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,500,000 Underlying: Common Stock · 2,500,000 shares Expires 2033-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: All of the stock options were fully vested and exercisable as of the transaction date. Read SEC document |
| August 25, 2025 Filed Aug 26, 2025 21:17 UTC |
ELITE PHARMACEUTICALS INC /NV/EVP Operations
|
Exercise / conversionCommon Stock | 2,500,000 | $0.03 | $75,000.00 |
DisclosureSEC source: 0001493152-25-012347 · ownership.xml · nonDerivative · entry 2 ELITE PHARMACEUTICALS INC /NV/ · CIK 0001053369 · EVP Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,300,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 22, 2025 Filed Aug 26, 2025 21:17 UTC |
ELITE PHARMACEUTICALS INC /NV/EVP Operations
|
SaleCommon Stock | 500,000 | $0.52 | $262,150.00 |
DisclosureSEC source: 0001493152-25-012347 · ownership.xml · nonDerivative · entry 1 ELITE PHARMACEUTICALS INC /NV/ · CIK 0001053369 · EVP Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,800,000 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.52 to $0.56, inclusive. The reporting person undertakes to provide to Elite Phannaceuticals, any security holder of Elite Pharmaceuticals, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote(1) to this Form 4 Read SEC document |
| July 10, 2025 Filed Jul 25, 2025 22:05 UTC |
Kirkov KirkoChief Commercial Officer
|
PurchaseCommon Stock | 16,366 | $0.59 | $9,639.57 |
DisclosureSEC source: 0001946043-25-000002 · primary_doc.xml · nonDerivative · entry 1 Kirkov Kirko · CIK 0001946043 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,366 Read SEC document |
| July 08, 2025 Filed Jul 10, 2025 20:17 UTC |
Plassche DouglasEVP Operations
|
SaleStock Options (right to buy) | 200,000 | $0.58 | $115,800.00 |
DisclosureSEC source: 0001641172-25-018593 · ownership.xml · nonDerivative · entry 1 Plassche Douglas · CIK 0001600946 · EVP Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,300,000 Read SEC document |
| July 03, 2025 Filed Jul 8, 2025 20:15 UTC |
Plassche DouglasEVP Operations
|
Exercise / conversionStock Options (right to buy) · Derivative | 2,500,000 | $0.00 Strike: $0.03 | $0.00 |
DisclosureSEC source: 0001641172-25-018199 · ownership.xml · derivative · entry 2 Plassche Douglas · CIK 0001600946 · EVP Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,000,000 Underlying: Common Stock · 2,500,000 shares Expires 2033-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: All of the stock options were fully vested and exercisable as of the transaction date. Read SEC document |
| July 03, 2025 Filed Jul 8, 2025 20:15 UTC |
Plassche DouglasEVP Operations
|
Exercise / conversionStock Options (right to buy) | 2,500,000 | $0.03 | $75,000.00 |
DisclosureSEC source: 0001641172-25-018199 · ownership.xml · nonDerivative · entry 1 Plassche Douglas · CIK 0001600946 · EVP Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,500,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 24, 2024 Filed Oct 28, 2024 21:23 UTC |
Plassche DouglasSVP of Operations
|
SaleCommon Stock | 333,932 | $0.51 | $170,305.32 |
DisclosureSEC source: 0001493152-24-042726 · ownership.xml · nonDerivative · entry 2 Plassche Douglas · CIK 0001600946 · SVP of Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Read SEC document |
| October 23, 2024 Filed Oct 28, 2024 21:23 UTC |
Plassche DouglasSVP of Operations
|
SaleCommon Stock | 800,000 | $0.49 | $392,000.00 |
DisclosureSEC source: 0001493152-24-042726 · ownership.xml · nonDerivative · entry 1 Plassche Douglas · CIK 0001600946 · SVP of Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 333,932 Read SEC document |
| March 29, 2024 Filed Apr 2, 2024 20:58 UTC |
Hakim Nasrat ADirector · CEO, President · 10% owner
|
GrantCommon Stock | 49,534,368 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-24-012832 · ownership.xml · nonDerivative · entry 1 Hakim Nasrat A · CIK 0001583742 · Director · CEO, President · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 216,649,250 F1 · shares: Shares issued in settlement of compensation owed to the Reporting Person pursuant to his Employment Agreement with the issuer, dated August 1, 2013, as amended. Read SEC document |
| December 29, 2023 Filed Dec 29, 2023 19:21 UTC |
Hakim Nasrat ADirector · CEO, President · 10% owner
|
GrantCommon Stock | 2,223,147 | $0.07 | $153,397.14 |
DisclosureSEC source: 0001583742-23-000001 · primary_doc.xml · nonDerivative · entry 1 Hakim Nasrat A · CIK 0001583742 · Director · CEO, President · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · Kristine Hakim Disclosed balance after: 2,223,147 F1 · shares: Shares issued in lieu of cash compensation for Pharmacovigilance and Medical Affairs consulting work during 2018-2022. Read SEC document |
| November 22, 2023 Filed Nov 28, 2023 00:05 UTC |
WHITNELL JEFFREY ADirector
|
GrantCommon Stock | 547,657 | $0.04 | $19,989.48 |
DisclosureSEC source: 0001324222-23-000003 · primary_doc.xml · nonDerivative · entry 1 WHITNELL JEFFREY A · CIK 0001126562 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,187,020 Read SEC document |
| November 22, 2023 Filed Nov 27, 2023 23:58 UTC |
Caskey Davis SDirector
|
GrantCommon Stock | 547,657 | $0.04 | $19,989.48 |
DisclosureSEC source: 0001324222-23-000002 · primary_doc.xml · nonDerivative · entry 1 Caskey Davis S · CIK 0001463732 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,049,436 Read SEC document |
| November 22, 2023 Filed Nov 27, 2023 23:50 UTC |
Dash Barry HDirector
|
GrantCommon Stock | 547,657 | $0.04 | $19,989.48 |
DisclosureSEC source: 0001324222-23-000001 · primary_doc.xml · nonDerivative · entry 1 Dash Barry H · CIK 0001324222 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,235,555 Read SEC document |
| January 03, 2023 Filed Jun 26, 2023 16:46 UTC |
Plassche DouglasExecutive VP Operations
|
GrantOptions · Derivative | 7,500,000 | $0.03 Strike: $0.03 | $225,000.00 |
DisclosureSEC source: 0001600946-23-000001 · primary_doc.xml · derivative · entry 1 Plassche Douglas · CIK 0001600946 · Executive VP Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,500,000 Underlying: Common Stock · 7,500,000 shares Expires 2033-01-03 F1 · shares: Options were awarded by the Board of Directions as part of Mr. Plassche's employment retention agreement. F2 · derivative.exercise_date: The options will best over a three-year period, commencing one year from the date of issuance. The first third will vest on January 3, 2024. Read SEC document |
| September 06, 2022 Filed Nov 14, 2022 16:10 UTC |
Kirkov KirkoChief Commercial Officer
|
GrantOptions · Derivative | 3,000,000 | $0.04 Strike: $0.04 | $105,000.00 |
DisclosureSEC source: 0001946043-22-000003 · primary_doc.xml · derivative · entry 1 Kirkov Kirko · CIK 0001946043 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000,000 Underlying: Common Stock · 3,000,000 shares Expires 2032-09-06 F1 · shares: The Board of Directors approved and awarded options on November 10, 2022, as part of Mr. Kirkov's employment agreement dated September 6, 2022. F2 · derivative.exercise_date: The options will vest over a three-year period, commencing one year from the date of issuance. The first third will vest on September 6, 2023. Read SEC document |
| August 28, 2022 Filed Aug 29, 2022 17:49 UTC |
WHITNELL JEFFREY ADirector
|
GrantCommon Stock | 459,536 | $0.04 | $19,989.82 |
DisclosureSEC source: 0001324222-22-000003 · primary_doc.xml · nonDerivative · entry 1 WHITNELL JEFFREY A · CIK 0001126562 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,639,363 Read SEC document |
| August 28, 2022 Filed Aug 29, 2022 17:40 UTC |
Caskey Davis SDirector
|
GrantCommon Stock | 459,536 | $0.04 | $19,989.82 |
DisclosureSEC source: 0001324222-22-000002 · primary_doc.xml · nonDerivative · entry 1 Caskey Davis S · CIK 0001463732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,501,779 Read SEC document |
| August 28, 2022 Filed Aug 29, 2022 17:35 UTC |
Dash Barry HDirector
|
GrantCommon Stock | 459,536 | $0.04 | $19,989.82 |
DisclosureSEC source: 0001324222-22-000001 · primary_doc.xml · nonDerivative · entry 1 Dash Barry H · CIK 0001324222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,687,898 Read SEC document |
| May 16, 2022 Filed Jul 7, 2022 20:53 UTC |
Chen Robert C JCFO, Secretary, Treasurer
|
GrantOptions · Derivative | 900,000 | $0.04 Strike: $0.04 | $36,000.00 |
DisclosureSEC source: 0001931826-22-000002 · primary_doc.xml · derivative · entry 1 Chen Robert C J · CIK 0001931826 · CFO, Secretary, Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 900,000 Underlying: Common Stock · 900,000 shares Expires 2032-05-16 F1 · shares: Options were awarded by the Board of Directions as part of Mr. Chen's employment agreement. F2 · derivative.exercise_date: The options will best over a three-year period, commencing one year from the date of issuance. The first third will vest on May 16, 2023. Read SEC document |
| June 30, 2021 Filed Jul 1, 2021 22:36 UTC |
WHITNELL JEFFREY ADirector
|
GrantCommon Stock | 295,570 | $0.07 | $20,010.09 |
DisclosureSEC source: 0001324222-21-000003 · primary_doc.xml · nonDerivative · entry 1 WHITNELL JEFFREY A · CIK 0001126562 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,179,827 Read SEC document |
| June 30, 2021 Filed Jul 1, 2021 22:30 UTC |
Caskey Davis SDirector
|
GrantCommon Stock | 295,570 | $0.07 | $20,010.09 |
DisclosureSEC source: 0001324222-21-000002 · primary_doc.xml · nonDerivative · entry 1 Caskey Davis S · CIK 0001463732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,042,243 Read SEC document |
| June 30, 2021 Filed Jul 1, 2021 22:20 UTC |
Dash Barry HDirector
|
GrantCommon Stock | 295,570 | $0.07 | $20,010.09 |
DisclosureSEC source: 0001324222-21-000001 · primary_doc.xml · nonDerivative · entry 1 Dash Barry H · CIK 0001324222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,228,182 Read SEC document |
| May 17, 2021 Filed Jul 7, 2021 21:00 UTC |
Bregman MarcCFO, Secretary, Treasurer
|
GrantOptions · Derivative | 300,000 | $0.06 Strike: $0.06 | $16,860.00 |
DisclosureSEC source: 0001863113-21-000002 · primary_doc.xml · derivative · entry 1 Bregman Marc · CIK 0001863113 · CFO, Secretary, Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 300,000 shares Expires 2031-05-17 F1 · shares: Options were awarded by the Board of Directors as part of Mr. Bregman's employment agreement. F2 · derivative.exercise_date: The options will vest over a three-year period, commencing one year from the date of issuance. The first third will vest on May 17, 2022 Read SEC document |
| August 24, 2020 Filed Aug 26, 2020 17:29 UTC |
Hakim Nasrat ADirector · CEO & President · 10% owner
|
ConversionSeries J Convertible Preferred Shares · Derivative | 24.0344 | $0.00 | $0.00 |
DisclosureSEC source: 0001583742-20-000002 · primary_doc.xml · derivative · entry 3 Hakim Nasrat A · CIK 0001583742 · Director · CEO & President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 158,017,321 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The preferred shares are convertible into shares of common stock at a rate of 6,576,878.18 shares of common stock for each whole share of preferred stock, effectively $0.1521 per share of common stock. F1 · price: The preferred shares are convertible into shares of common stock at a rate of 6,576,878.18 shares of common stock for each whole share of preferred stock, effectively $0.1521 per share of common stock. F2 · derivative.exercise_date: Shareholder Approval was obtained on June 23, 2020 for an increase in the number of authorized shares of common stock to permit full conversion of the preferred stock. F3 · derivative.expiration_date: None Read SEC document |
| August 24, 2020 Filed Aug 26, 2020 17:29 UTC |
Hakim Nasrat ADirector · CEO & President · 10% owner
|
ConversionCommon Stock | 158,017,321 | $0.00 | $0.00 |
DisclosureSEC source: 0001583742-20-000002 · primary_doc.xml · nonDerivative · entry 1 Hakim Nasrat A · CIK 0001583742 · Director · CEO & President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 167,114,882 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 20, 2020 Filed Aug 24, 2020 18:18 UTC |
Caskey Davis SDirector
|
GrantCommon Stock | 516,781 | $0.09 | $45,011.63 |
DisclosureSEC source: 0001324222-20-000004 · primary_doc.xml · nonDerivative · entry 1 Caskey Davis S · CIK 0001463732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 746,673 Read SEC document |
| August 20, 2020 Filed Aug 24, 2020 18:24 UTC |
Plassche DouglasSVP Operations
|
GrantCommon Stock | 71,739 | $0.09 | $6,284.34 |
DisclosureSEC source: 0001324222-20-000005 · primary_doc.xml · nonDerivative · entry 1 Plassche Douglas · CIK 0001600946 · SVP Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,133,932 Read SEC document |
| August 20, 2020 Filed Aug 24, 2020 18:15 UTC |
WHITNELL JEFFREY ADirector
|
GrantCommon Stock | 516,781 | $0.09 | $45,011.63 |
DisclosureSEC source: 0001324222-20-000003 · primary_doc.xml · nonDerivative · entry 1 WHITNELL JEFFREY A · CIK 0001126562 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,884,257 Read SEC document |
| August 20, 2020 Filed Aug 24, 2020 18:11 UTC |
Dash Barry HDirector
|
GrantCommon Stock | 516,781 | $0.09 | $45,011.63 |
DisclosureSEC source: 0001324222-20-000002 · primary_doc.xml · nonDerivative · entry 1 Dash Barry H · CIK 0001324222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,932,612 Read SEC document |
| June 30, 2020 Filed Jul 6, 2020 15:38 UTC |
Plassche DouglasSVP of Operations
|
GrantCommon Stock | 574,597 | $0.09 | $49,989.94 |
DisclosureSEC source: 0001600946-20-000001 · primary_doc.xml · nonDerivative · entry 1 Plassche Douglas · CIK 0001600946 · SVP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,062,193 F1 · shares: Represents 2018 and 2019 salary shares Read SEC document |
| February 26, 2018 Filed Feb 27, 2018 22:15 UTC |
Pfeifer Eugene MDirector
|
GrantCommon Stock | 161,374 | $0.12 | $19,994.24 |
DisclosureSEC source: 0001053369-18-000006 · primary_doc.xml · nonDerivative · entry 1 Pfeifer Eugene M · CIK 0001672351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 233,414 Read SEC document |
| February 26, 2018 Filed Feb 27, 2018 22:02 UTC |
Plassche DouglasSVP of Operations
|
GrantCommon Stock | 201,717 | $0.12 | $24,992.74 |
DisclosureSEC source: 0001053369-18-000005 · primary_doc.xml · nonDerivative · entry 1 Plassche Douglas · CIK 0001600946 · SVP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 487,596 Read SEC document |
| February 26, 2018 Filed Feb 27, 2018 21:59 UTC |
Ward Carter JulianCFO, Sec., Treas.
|
GrantCommon Stock | 242,060 | $0.12 | $29,991.23 |
DisclosureSEC source: 0001053369-18-000004 · primary_doc.xml · nonDerivative · entry 1 Ward Carter Julian · CIK 0001467874 · CFO, Sec., Treas. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,127,364 Read SEC document |
| February 26, 2018 Filed Feb 27, 2018 21:53 UTC |
WHITNELL JEFFREY ADirector
|
GrantCommon Stock | 161,374 | $0.12 | $19,994.24 |
DisclosureSEC source: 0001053369-18-000003 · primary_doc.xml · nonDerivative · entry 1 WHITNELL JEFFREY A · CIK 0001126562 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,367,476 Read SEC document |
| February 26, 2018 Filed Feb 27, 2018 21:42 UTC |
Dash Barry HDirector
|
GrantCommon Stock | 161,374 | $0.12 | $19,994.24 |
DisclosureSEC source: 0001053369-18-000002 · primary_doc.xml · nonDerivative · entry 1 Dash Barry H · CIK 0001324222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,415,831 Read SEC document |
| February 26, 2018 Filed Feb 27, 2018 21:37 UTC |
Caskey Davis SDirector
|
GrantCommon Stock | 161,374 | $0.12 | $19,994.24 |
DisclosureSEC source: 0001053369-18-000001 · primary_doc.xml · nonDerivative · entry 1 Caskey Davis S · CIK 0001463732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 229,892 Read SEC document |
| April 28, 2017 Filed May 3, 2017 22:17 UTC |
Hakim Nasrat ADirector · CEO & President · 10% owner
|
OtherWarrants · Derivative | 79,008,661 | $0.00 Strike: $0.15 | $0.00 |
DisclosureSEC source: 0001583742-17-000002 · primary_doc.xml · derivative · entry 4 Hakim Nasrat A · CIK 0001583742 · Director · CEO & President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,008,661 Underlying: Common Stock · 79,008,661 shares Expires 2027-04-28 F1 · kind: The common shares were returned to the company in exchange for the Series J Convertible Preferred Shares and warrants issued by the company. F3 · derivative.exercise_date: The date that Shareholder Approval is obtained for an increase in the number of authorized shares of common stock to permit full conversion of the preferred stock and exercise of the warrants. Read SEC document |
| April 28, 2017 Filed May 3, 2017 22:17 UTC |
Hakim Nasrat ADirector · CEO & President · 10% owner
|
OtherSeries J Convertible Preferred Shares · Derivative | 24.0344 | $1,000,000.00 Strike: $1,000,000.00 | $24,034,400.00 |
DisclosureSEC source: 0001583742-17-000002 · primary_doc.xml · derivative · entry 3 Hakim Nasrat A · CIK 0001583742 · Director · CEO & President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24.0344 Underlying: Common Stock · 158,017,321 shares Expires not disclosed F1 · security: The common shares were returned to the company in exchange for the Series J Convertible Preferred Shares and warrants issued by the company. F1 · kind: The common shares were returned to the company in exchange for the Series J Convertible Preferred Shares and warrants issued by the company. F2 · shares: The preferred shares are convertible into shares of common stock at a rate of 6,576,878.18 shares of common stock for each whole share of preferred stock. F3 · derivative.exercise_date: The date that Shareholder Approval is obtained for an increase in the number of authorized shares of common stock to permit full conversion of the preferred stock and exercise of the warrants. F4 · derivative.expiration_date: None. F2 · balance_after: The preferred shares are convertible into shares of common stock at a rate of 6,576,878.18 shares of common stock for each whole share of preferred stock. Read SEC document |
| April 28, 2017 Filed May 3, 2017 22:17 UTC |
Hakim Nasrat ADirector · CEO & President · 10% owner
|
OtherCommon Stock | 158,017,321 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001583742-17-000002 · primary_doc.xml · nonDerivative · entry 1 Hakim Nasrat A · CIK 0001583742 · Director · CEO & President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,097,561 F1 · kind: The common shares were returned to the company in exchange for the Series J Convertible Preferred Shares and warrants issued by the company. F1 · shares: The common shares were returned to the company in exchange for the Series J Convertible Preferred Shares and warrants issued by the company. F1 · price: The common shares were returned to the company in exchange for the Series J Convertible Preferred Shares and warrants issued by the company. Read SEC document |
| February 23, 2017 Filed Feb 27, 2017 23:41 UTC |
Ward Carter JulianDirector
|
GrantCommon Stock | 133,019 | $0.23 | $29,995.78 |
DisclosureSEC source: 0001053369-17-000004 · primary_doc.xml · nonDerivative · entry 1 Ward Carter Julian · CIK 0001467874 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,885,304 Read SEC document |
| February 23, 2017 Filed Feb 28, 2017 00:08 UTC |
Pfeifer Eugene MDirector
|
GrantCommon Stock | 72,040 | $0.20 | $14,588.10 |
DisclosureSEC source: 0001053369-17-000007 · primary_doc.xml · nonDerivative · entry 1 Pfeifer Eugene M · CIK 0001672351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,040 Read SEC document |
| February 23, 2017 Filed Feb 27, 2017 23:59 UTC |
Caskey Davis SDirector
|
GrantCommon Stock | 68,518 | $0.20 | $13,443.23 |
DisclosureSEC source: 0001053369-17-000006 · primary_doc.xml · nonDerivative · entry 1 Caskey Davis S · CIK 0001463732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,518 Read SEC document |
| February 23, 2017 Filed Feb 27, 2017 23:46 UTC |
Plassche DouglasSVP of Operations
|
GrantCommon Stock | 110,849 | $0.23 | $24,996.45 |
DisclosureSEC source: 0001053369-17-000005 · primary_doc.xml · nonDerivative · entry 1 Plassche Douglas · CIK 0001600946 · SVP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 285,879 Read SEC document |
| February 23, 2017 Filed Feb 27, 2017 23:26 UTC |
WHITNELL JEFFREY ADirector
|
GrantCommon Stock | 88,679 | $0.23 | $19,997.11 |
DisclosureSEC source: 0001053369-17-000003 · primary_doc.xml · nonDerivative · entry 1 WHITNELL JEFFREY A · CIK 0001126562 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,206,102 Read SEC document |
| February 23, 2017 Filed Feb 27, 2017 23:09 UTC |
Hakim Nasrat ADirector · CEO & President · 10% owner
|
GrantCommon Stock | 2,216,992 | $0.23 | $499,931.70 |
DisclosureSEC source: 0001053369-17-000001 · primary_doc.xml · nonDerivative · entry 1 Hakim Nasrat A · CIK 0001583742 · Director · CEO & President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,143,785 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.